MNKD MannKind Corporation

$3.75▼ -1.06% Healthcare Other
After hours $3.80▲ +1.21% Sep 11, 7:59 PM ET
Volume 2.47M Avg Volume (10D) 3.02M
Key Metrics & Fundamentals
Market Cap
$1.21B
P/E Ratio
–
Div Yield
–%
52W Range
2.23 - 6.51
% vs 50 MA
-6.74%
% vs 200 MA
-9.32%
RSI-14
41.7
MACD Histogram
-0.0300
Beta (1Y vs SPY)
1.12
Free Cash Flow
-$23.45M
Gross Rev
$109.38M
Gross Profit
$79.84M
EBITDA
$1.98M
COGS
$29.54M
Operating Exp
$80.67M
Operating Income
-$835,000
EBIT
-$835,000
Pretax Income
-$19.14M
Net Income
-$19.03M
EPS (Diluted)
-0.06
Price & Volume History
Loading chart…
Recent News
MannKind Expands Into Weight Loss With Rose Pharma Deal – Here’s What Investors Are Watching
Stocktwits · Sep 9, 2026 12:36 PM
MannKind, Rose Pharma Sign Deal to Develop Weight-Management Drug
MT Newswires · Sep 9, 2026 11:08 AM
MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management
GlobeNewswire · Sep 9, 2026 10:30 AM
MannKind to Present at Upcoming Investor Conferences
GlobeNewswire · Sep 2, 2026 12:30 PM
MannKind (MNKD) Could Be 48% Undervalued Following Its Afrezza And Pipeline Narrative
Simply Wall St. · Aug 29, 2026 1:05 PM
FDA Accepts United Therapeutics' NDA Filing for Ralinepag in PAH
Zacks · Aug 28, 2026 1:22 PM
MannKind's Diversified Portfolio Seen Leading to Higher Revenue in H2, Wedbush Says
MT Newswires · Aug 6, 2026 4:27 PM
United Therapeutics Q2 Earnings Beat Estimates, Revenues Miss Mark
Zacks · Aug 6, 2026 1:03 PM
MannKind Corp (MNKD) (Q2 2026) Earnings Call Highlights: Record Revenue and Major Catalysts ...
GuruFocus.com · Aug 6, 2026 5:11 AM
MannKind Q2 Earnings Call Highlights
MarketBeat · Aug 6, 2026 3:03 AM
Financial Overview - Income Statement Quarterly

See MNKD's money flow as a full page

Social Sentiment
Avg +0.25 · 4 posts
DDDiscussionHere’s Why MannKind Corporation (NASDAQ:MNKD) Is Among the Best Diabetes Stocks to Buy Under $10
r/wallstreetbets · Jan 31, 2025
The comments express significant skepticism and negative historical performance, indicating a bearish sentiment.
negative +0.10
Discussion$UTHR and $MNKD
r/wallstreetbets · Sep 16, 2024
The author discusses the potential for the company with relation to future developments.
positive +0.70
NewsEarningsDDPriceTargetAll You Need To Know About MannKind Corporation (MNKD) Before You Buy
r/wallstreetbets · Sep 9, 2024
The post highlights revenue growth, analyst forecasts, a Zacks Rank upgrade, and the innovative Afrezza product, indicating a bullish outlook.
positive +0.80
DDDiscussionLong in Mannkind Corporation
r/wallstreetbets · Jun 4, 2024
The post expresses concern about the product's market performance and describes Mannkind as 'just another company', indicating a bearish outlook.
negative -0.60
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙